Sterling Incorporated

Sterling Pharma Solutions is a global contract development and manufacturing organization (CDMO) specializing in complex small molecule API development and manufacturing. The company provides a full suite of services from discovery-stage chemistry to commercial-scale production, with specific expertise in hazardous chemistry and high-potency APIs (HPAPI). Sterling has expanded its service offering through strategic acquisitions, notably adding antibody-drug conjugate (ADC) development and conjugation capabilities. Headquartered in the UK, Sterling operates a global network of facilities, including sites in the United States and Ireland, serving a diverse client base of virtual biotechs and large pharmaceutical companies.